Background: Access to acute neurological care is limited. Especially in nonurban areas, and owing to uncertainties in diagnosing stroke, non-neurologists often misinterpret stroke symptoms. We evaluated the profile of patients with suspected stroke and the accuracy of the admission diagnosis ‘stroke’ in the setting of a specialized neurological emergency department in a nonurban region. Methods: In this prospective observational study, (1) data from all 4,174 patients with the discharge diagnosis ‘stroke’ and (2) data from 1,800 consecutive patients (3 cohorts per year over 3 years) with the admission diagnosis ‘stroke’ were included over a 3-year period. Results: The positive predictive value of the admission diagnosis ‘stroke’ was 0.34; the negative predictive value was 0.97. The rate of misdiagnosis significantly correlated with age and time from symptom onset to presentation. During the study period, the proportion of patients with the admission diagnosis ‘stroke’ admitted early after symptom onset increased from 19.9 to 27.8% within 3 h and from 26.4 to 32.7% within 4.5 h, respectively. Thrombolysis rates increased (from 9.4 to 15.4%). Conclusion: The uncertainties in interpreting stroke symptoms and the lack of facilities for treating emergency stroke in nonurban areas may be outweighed by offering access to a specialized neurological emergency room, thus rectifying any misinterpretation of stroke symptoms and shortening in-hospital time windows for treatment. Still, the rate of misdiagnosis is high, requiring expensive resources, despite the constant flow of information to the public. Therefore, more prospective data comparing different emergency room settings are needed which focus in particular on patients with the admission diagnosis ‘stroke’.

1.
Truelsen T, Piechowski-Jozwiak B, Bonita R, Mathers C, Bogousslavsky J, Boysen G: Stroke incidence and prevalence in Europe: a review of available data. Eur J Neurol 2006;13:581–598.
2.
Caro JJ, Huybrechts KF, Duchesne I; for the Stroke Economic Analysis Group: Management patterns and costs of acute ischemic stroke: an international study. Stroke 2000;31:582–590.
3.
Kavanagh S, Knapp M, Patel A: Costs and disability among stroke patients. J Public Health Med 1999;2:385–394.
4.
Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D; ECASS investigators: Thrombolysis with alteplase 3 to 4.5 h after acute ischemic stroke. N Engl J Med 2008;359:1317–1329.
5.
Adams HP Jr, Adams RJ, Brott T, del Zoppo GJ, Furlan A, Goldstein LB, Grubb RL, Higashida R, Kidwell C, Kwiatkowski TG, Marler JR, Hademenos GJ; Stroke Council of the American Stroke Association: Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003;34:1056–1083.
6.
European Stroke Initiative Recommendations for Stroke Management – Update 2003. Cerebrovasc Dis 2003;16:311–337.
7.
Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S; ATLANTIS Trials investigators, ECASS Trials investigators, NINDS rt-PA Study Group investigators: Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363:768–774.
8.
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–1587.
9.
Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, Amelink GJ, Schmiedeck P, Schwab S, Rothwell PM, Bousser MG, van der Worp HB, Hacke W; DECIMAL, DESTINY, and HAMLET investigators: Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007;6:215–222.
10.
Nor AM, Ford GA: Misdiagnosis of stroke. Expert Rev Neurother 2007;7:989–1001.
11.
Greenlund KJ, Neff LJ, Zheng ZJ, Keenan NL, Giles WH, Ayala CA, Croft JB, Mensah GA: Low public recognition of major stroke symptoms. Am J Prev Med 2003;25:315–319.
12.
Rønning OM, Thommessen B: Stroke: when the diagnosis is wrong. Tidsskr Nor Laegeforen 2005;125:1655–1657.
13.
Schneider AT, Pancioli AM, Khoury JC, Rademacher E, Tuchfarber A, Miller R, Woo D, Kissela B, Broderick JP: Trends in community knowledge of the warning signs and risk factors for stroke. JAMA 2003;289:343–346.
14.
Pancioli AM, Broderick J, Kothari R, Brott T, Tuchfarber A, Miller R, Khoury J, Jauch E: Public perception of stroke warning signs and knowledge of potential risk factors. JAMA 1998;279:1288–1292.
15.
Deng YZ, Reeves MJ, Jacobs BS, Birbeck GL, Kothari RU, Hickenbottom SL, Mullard AJ, Wehner S, Maddox K, Majid A: IV tissue plasminogen activator use in acute stroke: experience from a statewide registry. Neurology 2006;66:306–312.
16.
Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM: Why are stroke patients excluded from tPA therapy? An analysis of patient eligibility. Neurology 2001;56:1015–1020.
17.
Heuschmann P, Berger K, Misselwitz B, Hermanek P, Leffmann C, Adelmann M, Buecker-Nott HJ, Rother J, Neundoerfer B, Kolominsky-Rabas PL; for the German Stroke Registers Study Group and for the Competence Net Stroke: Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality. The German Stroke Registers Study Group. Stroke 2003;34:1106–1113.
18.
Handschu R, Garling A, Heuschmann PU, Kolominsky-Rabas PL, Erbguth F, Neundorfer B: Acute stroke management in the local general hospital. Stroke 2001;32:866–870.
19.
Heidrich J, Heuschmann PU, Kolominsky- Rabas P, Rudd AG, Wolfe CD: Variations in the use of diagnostic procedures after acute stroke in Europe: results from the BIOMED II study of stroke care. Eur J Neurol 2007;14:255–261.
20.
European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee: Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008;25:457–507.
21.
Cho AH, Sohn SI, Han MK, Lee DH, Kim JS, Choi CG, Sohn CH, Kwon SU, Suh DC, Kim SJ, Bae HJ, Kang DW: Safety and efficacy of MRI-based thrombolysis in unclear-onset stroke. A preliminary report. Cerebrovasc Dis 2008;25:572–579.
22.
Kohrmann M, Juttler E, Huttner HB, Nowe T, Schellinger PD: Acute stroke imaging for thrombolytic therapy – an update. Cerebrovasc Dis 2007;24:161–169.
23.
Ringleb PA, Schwark C, Kohrmann M, Kulkens S, Juttler E, Hacke W, Schellinger PD: Thrombolytic therapy for acute ischaemic stroke in octogenarians: selection by magnetic resonance imaging improves safety but does not improve outcome. J Neurol Neurosurg Psychiatry 2007;78:690–693.
24.
Adams HP, Brott TG, Crowell RM, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Marler JR, Woolson RF, Zivin JA, Feinberg W, Mayberg M: Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994;25:1901–1914.
25.
Moulin T, Sablot D, Vidry E, Belahsen F, Berger E, Lemounaud P, Tatu L, Vuillier F, Cosson A, Revenco E, Capellier G, Rumbach L: Impact of emergency room neurologists on patient management and outcome. Eur Neurol 2003;50:207–214.
26.
Norris JW, Hachinski VC: Misdiagnosis of stroke. Lancet 1982;319:328–331.
27.
Libman R, Wirkowski E, Alvir J, Rao TH: Conditions that mimic stroke in the emergency department: implications for acute stroke trials. Arch Neurol 1995;52:1119–1122.
28.
Harbison J, Hossain O, Jenkinson D, Davis J, Louw SJ, Ford GA: Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face arm speech test. Stroke 2003;34:71–76.
29.
Nor AM, Davis J, Sen B, Shipsey D, Louw SJ, Dyker AG, Davis M, Ford GA: The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument. Lancet Neurol 2005;4:727–734.
30.
Townend E, Tinson D, Kwan J, Sharpe M: Fear of recurrence and beliefs about preventing recurrence in persons who have suffered a stroke. J Psychosom Res 2006;61:747–755.
31.
Maestroni A, Mandelli C, Manganaro D, Zecca B, Rossi P, Monzani V, Torgano G: Factors influencing delay in presentation for acute stroke in an emergency department in Milan, Italy. Med J 2008;25:340–345.
32.
Derex L, Adeleine P, Nighoghossian N, Honnorat J, Trouillas P: Factors influencing early admission in a French stroke unit. Stroke 2002;33:153–159.
33.
Harraf F, Sharma AK, Brown MM, Lees KR, Vass RI, Kalra L: A multicentre observational study of presentation and early assessment of acute stroke. BMJ 2002;325:17.
34.
Broadley SA, Thompson PD: Time to hospital admission for acute stroke: an observational study. Med J Aust 2003;178:329–331.
35.
Joubert J, Prentice LF, Moulin T, Liaw ST, Joubert LB, Preux PM, Ware D, Medeiros de Bustos E, McLean A: Stroke in rural areas and small communities. Stroke 2008;39:1920–1928.
36.
Hess DC, Wang S, Hamilton W, Lee S, Pardue C, Waller JL, Gross H, Nichols F, Hall C, Adams RJ: REACH: clinical feasibility of a rural telestroke network. Stroke 2005;36:2018–2020.
37.
Rose KM, Rosamond WD, Huston SL, Murphy CV, Tegeler CH: Predictors of time from hospital arrival to initial brain-imaging among suspected stroke patients: the North Carolina Collaborative Stroke Registry. Stroke 2008;39:3262–3267.
38.
Citerio G, Galli D, Pesenti A: Early stroke care in Italy – a steep way ahead: an observational study. Emerg Med J 2006;23:608–611.
39.
Romano JG, Muller N, Merino JG, Forteza AM, Koch S, Rabinstein AA: In-hospital delays to stroke thrombolysis: paradoxical effect of early arrival. Neurol Res 2007;29:664–666.
40.
Mehdiratta M, Woolfenden AR, Chapman KM, Johnston DC, Schulzer M, Beckman J, Teal PA: Reduction in IV t-PA door to needle times using an Acute Stroke Triage Pathway. Can J Neurol Sci 2006;33:214–216.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.